Back Bay offers an intriguing mix of life science consulting and investment banking—an intersection that appears to be proving particularly lucrative, judging by the firm’s recent growth rates. Supporting that growth is a company culture that is dedicated to long-term development both for client relationships and career development.
Major Departments/Practice Areas
Major Office Locations
Back Bay insiders are typically effusive about life at the firm, with especially lavish praise for the company’s open, inclusive culture and career development opportunities. And with good reason: the company has been going from strength to strength in recent years, carving out a distinct niche in the life sciences sector that is supported by a thriving investment bank arm.
Of course, the typical industry spikes in hours and stress are on show at Back Bay as well, but the firm seems to take pains to try to mitigate the worst of these, seeking and incorporating feedback from consultants along the way.
While base compensation is lower than at some industry competitors, Back Bay operates a bonus-heavy model that, should the company’s recent growth ...
Back Bay Life Science Advisors provides life science strategy and investment banking to the global life science industry, including pharma, biotech, MedTech, startups, academia, and investors. From its offices in Boston, Toronto and Frankfurt, Back Bay teams provide consulting services to those on the forefront of the ever-evolving field of life sciences.
Back Bay works with companies of all sizes across the US and global life science markets, across every stage, sector, geography, and therapeutic area. Back Bay strategy and banking teams guide companies on technology and drug development, from planning and initial concept to product commercialization, franchising and licensing, M&A, divestiture, and more.
With headquarters in Boston's Back Bay neighborhood, Back Bay teams are comprised of scienti...
Based out of Boston’s Back Bay—known as “the center of the nation’s biotechnology industry”—we are a boutique-size firm with global reach and reputation. We excel at guiding life science companies and their investors through complex decisions. Our teams work closely with our client partners in leading life science hubs in the United States, Europe and beyond. Our approach is unique in that we among the first and only to integrate life science strategy with investment banking execution so we are a trusted partner through every stage of product development. Our strategy clients more often than not turn into our investment banking clients, as we shepherd products from clinic to development, into broad use and often through M&A needs.